[Held on September 26th] The 29th Future of Surgery: AI Analysis of Soft Tissue Tumor Reconstruction and the Cutting Edge of Bone and Soft Tissue Tumor Surgery
AI translatedAbout this session
For the 29th "Future of Surgery" event, we are pleased to welcome Dr. Akira Kawai, Head of the Department of Bone and Soft Tissue Tumors and Rehabilitation at the National Cancer Center Hospital, to give a lecture on "The Cutting Edge and Future Prospects of Bone and Soft Tissue Tumor Surgery 2025: Challenges in Limb Preservation and Quality of Life Improvement."
Malignant bone and soft tissue tumors (sarcomas) are characterized by being both malignant tumors and musculoskeletal disorders. Therefore, their treatment requires both an oncological perspective (improvement of life prognosis) and a perspective of maintaining and improving motor function (improvement of ADL and QOL).
This lecture will introduce the cutting edge and future prospects of bone and soft tissue tumor surgery in addressing this challenge. Specifically, it will discuss the types of surgical treatments and limb-preserving procedures being performed for malignant bone and soft tissue tumors, which are difficult to standardize due to the diversity of the tumors themselves, variations in surgical site (limbs vs. trunk) and tissue (bone vs. soft tissue), and the absolute small number of cases, as well as the multidisciplinary approaches that support them.
Those interested in the challenges and future prospects of bone and soft tissue tumor surgery, as well as the latest findings in supermicrosurgery, are encouraged to participate.
We are accepting applications until the last minute, so please invite your friends and apply together.
We will be inviting Dr. Akira Kawai, Chief, Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, for a lecture titled "Frontiers and Future Perspectives in Orthopedic Oncology 2025: Challenges Toward Limb Salvage and Improvement of Quality of Life."
Malignant bone and soft tissue tumors (sarcomas) are unique in that they are not only malignant tumors but also musculoskeletal diseases. Therefore, treatment must focus on both an oncological perspective (improving life prognosis) and a functional perspective (maintaining and improving activities of daily living and quality of life).
In this lecture, Dr. Kawai will provide an overview of the forefront and future outlook of orthopedic oncology surgery in addressing these challenges. He will discuss the surgical treatments and limb salvage procedures performed for malignant bone and soft tissue tumors. These procedures are particularly complex due to the diversity of tumors, variations in surgical sites (limbs vs. trunk) and tissues (bone vs. soft tissue), and the small number of cases. Dr. Kawai will also touch on the multidisciplinary approaches that support these treatments.
This is a must-attend event for anyone interested in the challenges and future prospects of orthopedic oncology surgery and the latest knowledge in supermicrosurgery.
Applications are accepted until the last minute, so please feel free to invite your colleagues and register.
Translated by Gemini.
|
Rare cancers
Bone and soft tissue tumors
Limb salvage surgery
|
Program
Koshima Isao
"AI Analysis of Reconstructive Surgery for Soft Tissue Tumors"
"AI analysis of reconstructive surgery for soft tissue tumors"
"The Cutting Edge and Future Prospects of Bone and Soft Tissue Tumor Surgery 2025: Challenges in Limb Preservation and Quality of Life Improvement"
Malignant bone and soft tissue tumors (sarcomas) are characterized by being both malignant tumors and musculoskeletal diseases. In treating them, an oncological perspective (improvement of life prognosis) and a perspective of maintaining and improving motor function (improvement of ADL and QOL) are indispensable. In this lecture, I would like to introduce the forefront and future prospects of bone and soft tissue tumor surgery in addressing this challenge. Specifically, given the diversity of the tumors themselves, the variations in surgical sites (limbs vs. trunk) and tissues (bone vs. soft tissue), and the absolute small number of cases, it is difficult to standardize surgical procedures for malignant bone and soft tissue tumors. I would like to introduce the types of surgical treatments and limb-preserving surgeries performed at one of Japan's leading high-volume centers in collaboration with various surgical departments, including plastic surgery, and discuss the multidisciplinary approach that supports them.
"Frontiers and Future Perspectives in Orthopedic Oncology 2025:
Challenges Toward Limb Salvage and Improvement of Quality of Life"
Malignant bone and soft tissue tumors (sarcomas) are unique in that they are not only malignant tumors but also musculoskeletal diseases. Therefore, treatment must address both an oncological perspective (improving life prognosis) and the need to maintain and improve motor function (enhancing ADL and QOL).
This lecture will cover the forefront and future outlook of orthopedic oncology surgery in resolved these challenges. Specifically, we will discuss the surgical treatments and limb salvage procedures performed at a high-volume center, in collaboration with various surgical departments, including plastic surgery. We will also explore the multidisciplinary approach that supports these treatments, which are particularly complex due to the diversity of tumors, variations in surgical sites (limbs vs. trunk) and tissues (bone vs. soft tissue), and the small number of cases, all of which make it difficult to standardize surgical procedures.
Translated by Gemini.